Doxycycline Patent Expiration
Doxycycline is Used for treating inflammatory lesions of rosacea. It was first introduced by Pfizer Laboratories Div Pfizer Inc
Doxycycline Patents
Given below is the list of patents protecting Doxycycline, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Oracea | US7749532 | Once daily formulations of tetracyclines | Dec 19, 2027 | Galderma Labs Lp |
Oracea | US8206740 | Once daily formulations of tetracyclines | Dec 24, 2025 | Galderma Labs Lp |
Oracea | US8394405 | Once daily formulations of tetracyclines |
Apr 07, 2024
(Expired) | Galderma Labs Lp |
Oracea | US8394406 | Once daily formulations of tetracyclines |
Apr 07, 2024
(Expired) | Galderma Labs Lp |
Oracea | US8470364 | Once daily formulations of tetracyclines |
Apr 07, 2024
(Expired) | Galderma Labs Lp |
Oracea | US8709478 | Once daily formulations of tetracyclines |
Apr 07, 2024
(Expired) | Galderma Labs Lp |
Oracea | US10058564 | Methods of treating acne |
Apr 05, 2022
(Expired) | Galderma Labs Lp |
Oracea | US7211267 | Methods of treating acne |
Apr 05, 2022
(Expired) | Galderma Labs Lp |
Oracea | US7232572 | Methods of treating rosacea |
Apr 05, 2022
(Expired) | Galderma Labs Lp |
Oracea | US8603506 | Methods of treating acne |
Apr 05, 2022
(Expired) | Galderma Labs Lp |
Oracea | US9241946 | Methods of treating acne |
Apr 05, 2022
(Expired) | Galderma Labs Lp |
Oracea | US5789395 | Method of using tetracycline compounds for inhibition of endogenous nitric oxide production |
Aug 30, 2016
(Expired) | Galderma Labs Lp |
Oracea | US5919775 | Method for inhibiting expression of inducible nitric oxide synthase with tetracycline |
Aug 30, 2016
(Expired) | Galderma Labs Lp |
Doxycycline's Family Patents

Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List